LVivo Software Application

The LVivo Software Application provides automated, quantitative assessment of left ventricular function by processing echocardiographic DICOM images using advanced image segmentation for border detection and tracking. Its methodology, validated through clinical studies comparing its ejection fraction, global and segmental strain, and wall motion analyses to established techniques, demonstrates accurate and reliable measurements, positioning it as an effective clinical decision support tool for cardiac evaluation.

The LVivo Software Application is designed for the non-invasive processing of previously acquired echocardiographic images to evaluate left ventricular (LV) function. It automatically analyzes DICOM-formatted echocardiogram movies, utilizing two orthogonal planes (4-chamber and 2-chamber views), to calculate global ejection fraction (EF) and measure cardiac strain, including global and segmental longitudinal strain. The system employs image segmentation algorithms for automated border detection, enabling frame-by-frame tracking of the LV, automated selection of end-diastolic (ED) and end-systolic (ES) frames, and volume calculation via Simpson's method. It supports manual editing of border points, automated rejection of false results, and provides results rapidly, functioning on both Windows and Linux operating systems. Clinical validation, particularly for its LVivoSG component which handles segmental analysis, focused on comparing its automated segmental wall motion and strain analysis against conventional methods like Siemens' Velocity Vector Imaging (VVI) and physician visual estimation. In a retrospective study using data from 100 subjects, LVivoSG's global longitudinal strain (GLS) measurements showed strong correlation (r=0.85) and inter-observer reliability (ICC=0.92) with VVI. Segmental wall motion scores from LVivoSG also demonstrated good agreement (ICC=0.86) with physicians' visual estimations. The software showed consistent performance across different coronary territories and individual myocardial segments, particularly for mid-ventricular regions, and high correlation was found between its own GLS and wall motion score index (r=0.87). The study concluded that LVivoSG provides accurate segmental LV function measurements, supporting its utility as a decision support tool for cardiac evaluation.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. What is the detailed methodology of the "image segmentation for border detection" algorithm, and how does it handle variations in image quality or anatomical abnormalities?; The study mentions a -3% average difference in Global Longitudinal Strain (GLS) between LVivoSG and VVI; what are the potential clinical implications of this systematic difference, and how were the different cutoff values for Normal/Abnormal GLS determined for each method?; How does the LVivoSG system's performance in segmental analysis (strain and wall motion) vary with different echocardiographic machine vendors or acquisition protocols, beyond DICOM compatibility?; While automated rejection of false results is listed as a feature of the LVivo system, what specific criteria are used for this rejection, and what is the observed rate of such rejections in typical clinical datasets?; Given the comparison of LVivoSG wall motion assessment with visual estimation, what was the documented inter-observer variability among the physicians performing the visual estimations, and how does this variability compare to LVivoSG's consistency?